Clinical Trial: A Study of MET233 in Combination With MET097 in Individuals With Obesity or Overweight With or Without Diabetes

U.S., April 12 -- ClinicalTrials.gov registry received information related to the study (NCT06924320) titled 'A Study of MET233 in Combination With MET097 in Individuals With Obesity or Overweight With or Without Diabetes' on April 03.

Brief Summary: This study is designed to test how well the combination of MET233 with MET097 works to treat individuals with obesity or overweight with or without diabetes.

Study Start Date: March 03

Study Type: INTERVENTIONAL

Condition: Obesity and Obesity-related Medical Conditions

Intervention: DRUG: MET233 and MET097

For subcutaneous administration

DRUG: Placebo

Sterile 0.9% (w/v) saline for subcutaneous administration.

DRUG: MET233

For subcutaneous administration

Recruitment Status: RECRUITI...